Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21101904 | 0.89 | ALDH1A1 (0.60) | ALDH1A1GAAMAPTNPSR1THRB | |
| SCHEMBL10310314 | 0.85 | GAA (0.62) | ALDH1A1GAAMAPTNPSR1THRB | |
| SCHEMBL23057067 | 0.80 | ALDH1A1 (0.66) | ALDH1A1GAAMAPTNPSR1THRB | |
| SCHEMBL21101771 | 0.77 | POLB (0.55) | POLB | |
| SCHEMBL26188145 | 0.76 | ALDH1A1 (0.64) | ALDH1A1GAAMAPTNPSR1THRB | |
| SCHEMBL24254500 | 0.76 | ALDH1A1 (0.78) | ALDH1A1GAAMAPTNPSR1THRB | |
| SCHEMBL24254504 | 0.75 | ALDH1A1 (0.63) | ALDH1A1GAAMAPTNPSR1THRB | |
| SCHEMBL24254495 | 0.74 | ALDH1A1 (1.00) | ALDH1A1GAAMAPTNPSR1THRB | |
| SCHEMBL21101772 | 0.73 | BRD4 (0.49) | ALDH1A1MAPTLMNAPOLBKMT2A | |
| SCHEMBL24254581 | 0.73 | ALDH1A1 (0.60) | ALDH1A1GAAMAPTNPSR1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019111225-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS | AVALIV THERAPEUTICS (US) | 2019-06-13 | — | — | WO | disclosed |